NewsletterScan
Monthly reportHealthMonth to date

Semaglutide in Newsletters: October 2026

So far in October 2026, Semaglutide came up in 7 newsletters across 7 issues, up from 3 newsletters in September. Most coverage came from Exponential View, Dr. Gordon | Obesity Medicine and Greg Katz, MD. The busiest day was Oct 12, with 2 mentions.

7
Newsletters
+133% vs September
7
Issues
8
Mentions
#1107
of 2,366 topics this month

Daily mentions

Oct 1Oct 23

Headlines mentioning Semaglutide

📈 What is bigger than AI?
Exponential View · Oct 12
Is Retatrutide the Best GLP Drug?
Greg Katz, MD · Oct 9
Estrogen For All?
The Savvy Patient · Oct 8
Amylin: The Next Big Obesity Drug Battleground
ON THE PEN · Oct 7
SciSchmoozing Peptides & More
SciSchmooze · Oct 5
The Case of the Missing Walk
Dr. Gordon | Obesity Medicine · Oct 3
The Honest Dose #21
The Honest Dose | by PeptideClear · Oct 2

Newsletters covering Semaglutide in Oct

Exponential View1 issueDr. Gordon | Obesity Medicine1 issueGreg Katz, MD1 issueThe Honest Dose | by PeptideClear1 issueThe Savvy Patient1 issueSciSchmooze1 issueON THE PEN1 issue

Covered alongside Semaglutide in Oct

Tirzepatide
5 shared issues
Glp-1
3 shared issues
Weight Loss
3 shared issues
Ozempic
3 shared issues
Obesity
2 shared issues
Diabetes
2 shared issues
GLP-1s
2 shared issues
Novo Nordisk
1 shared issue
Generative AI
1 shared issue
Blood Pressure
1 shared issue
FDA approval
1 shared issue
Hormone Replacement Therapy
1 shared issue

Semaglutide month by month

October 2026September 2026 · 3August 2026 · 2July 2026 · 1June 2026 · 1May 2026 · 1

Track Semaglutide in your dashboard

Get alerts when this topic surges in newsletters. Free to start.

Sign up free

Semaglutide trend overview ·Top topics in October 2026 ·Top topics in September ·Trending now